Alexion Pharmaceuticals, Inc. (ALXN)

163.68
NASDAQ
Prev Close 157.54
Day Low/High 163.54 / 164.60
52 Wk Low/High 94.82 / 162.60
Exchange NASDAQ
Shares Outstanding 220.92B
Market Cap 34.80B
P/E Ratio 37.32
Div & Yield N.A. (N.A)
The Day Ahead: Positioning for 'Jobs Friday'

The Day Ahead: Positioning for 'Jobs Friday'

Stocks were poised for a moderately higher ahead of this highly anticipated monthly event.

Squinting for Playable Stocks

Squinting for Playable Stocks

Despite the massive upsurge, there are still a few interesting setups to consider here.

Searching for a Pulse

Searching for a Pulse

It's not that the market action is bad, it just isn't lively enough to support aggressive action.

Scrutinize Those Breakouts

Scrutinize Those Breakouts

Some breakouts, like that of Apple lately, cannot be taken at face value -- especially if they lack volume.

Strong Volume Equals a Strong Foundation

Strong Volume Equals a Strong Foundation

EBIX broke out on Tuesday in heavy volume, which hints at institutional buying in this stock.

Off the Charts

Off the Charts

Keep your risk down at this point as the market still has a lot to prove.

More Safe-Haven Ideas

More Safe-Haven Ideas

Consider this strategy to help protect your portfolio as what could be a very treacherous earnings season approaches.

Biotech Is Booming

Biotech Is Booming

Despite the solid performance so far this year, there's still time to get on board and ride the profit train.

Big-Cap Momentum Names Still Hold Sway

Money is still flowing into some market-moving names, but not into small-caps.  

Fitz Bits: This Calls for Patience

Fitz Bits: This Calls for Patience

Alexion Pharma is too far above established support to be considered a buy at this point, so wait for a pullback closer to this key level.

Three Rock-Solid Names to Watch

Three Rock-Solid Names to Watch

If institutional buyers come into these stocks soon, we could have a nice year-end rally on our hands.

Don't Stay Married to Former Leaders

Don't Stay Married to Former Leaders

Focus on stocks that have come in no more than 30% off their recent highs as they have a good chance of forming sound bases and staging new breakouts.